Colgate-Palmolive (CL)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$88.77-1.47%
Close 2026-09-04 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · CL
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within consumer staples on a research-validated quality screen. As of 2026-09-04.
The screen ranks CL against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Consumer Staples names rated strong grew net income 64% of the time over the next year (vs 53% for the rest of the cohort, n=2094).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Continue and expand the three-year Strategic Growth and Productivity Program to align operations, optimize supply chain, and reduce overhead costs supporting the 2030 strategy.
Stated as a priority in 5 of last 5 quarters. Management expanded the Strategic Growth and Productivity Program in 2026-Q1, increasing estimated cumulative pretax charges to $350M-$550M and projecting annual savings of $200M-$300M. The program continues to be a key focus supporting the 2030 strategy, with ongoing execution and investment. The trajectory is delivering as management has increased scope and detailed expected savings.
“Executing against our 2030 strategy with a focus on premium, science-led innovation and omni-channel demand generation.”
“Board approved expansion of the Strategic Growth and Productivity Program with increased charges and projected savings.”
“Approved a three-year productivity program to drive future growth and support the 2030 strategy.”
“Deploying the Strategic Growth and Productivity Program to align organization and deliver consistent earnings growth.”
“Announced a new three-year productivity program to drive future growth and support the 2030 strategy.”
Maintain net sales growth target of 2% to 6% for full year 2026, including organic sales growth of 1% to 4%, despite challenging market conditions.
Stated as a priority in 5 of last 5 quarters. Revenue grew from $4.911B in 2026-Q1 to $5.361B in 2026-Q2, a 4.9% increase, consistent with the 2%-6% net sales growth guidance. Organic sales growth was 2.9% in 2026-Q1 and 2.4% in 2026-Q2, within the 1%-4% target. Management has maintained this growth target consistently, and the trajectory is delivering.
“The Company still expects net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.”
Drive supply chain optimization initiatives as part of the productivity program to improve agility and reduce costs.
Stated as a priority in 4 of last 5 quarters. The supply chain optimization is part of the Strategic Growth and Productivity Program aimed at improving agility and efficiencies. While specific financial metrics for supply chain improvements are not disclosed, the program's expanded scope and ongoing execution indicate continued focus. The trajectory shows persistent management commitment with limited direct financial disclosure.
Sustain and grow global market share leadership in toothpaste and manual toothbrush categories.
Stated as a priority in 5 of last 5 quarters. Management consistently reports maintaining leadership in toothpaste with global market share around 41.1%-41.3% and manual toothbrushes around 32.4%-32.7%. Market share data is stable and reflects sustained leadership. The trajectory is delivering consistent market position.
“Leadership in toothpaste continued with global market share at 41.3% year to date; manual toothbrushes at 32.7%.”
Continue to increase advertising spending to drive brand health, innovation, and category growth aligned with the 2030 strategy.
Stated as a priority in 5 of last 5 quarters. Advertising spending increased from $678M in 2025-Q2 to $777M in 2026-Q2, a 15% increase, supporting brand health and innovation. Management emphasizes continued strong investment aligned with the 2030 strategy. The trajectory is delivering increased advertising investment.
“Advertising increased 15% this quarter; strong levels of investment will continue in the back half of the year.”
Over the trailing year it converted 1.16x of net income into operating cash flow. Historically, Consumer Staples names rated neutral grew net income 52% of the time over the next year (vs 57% for the rest of the cohort, n=2083).
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, real (inflation-adjusted) rates, the broad stock market, Fed net liquidity (low R² over the window).
8 material management or governance events in the past 24 months, led by executive changes. Historically, Consumer Staples names rated neutral grew net income 51% of the time over the next year (vs 52% for the rest of the cohort, n=1251).
Not investment advice. As of 2026-09-04.
“The Company still expects net sales to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange.”
“The Company still expects net sales to be up low single digits, including a flat to low-single-digit negative impact from foreign exchange.”
“The Company still expects net sales to be up low single digits, including a flat to low-single-digit negative impact from foreign exchange.”
“The Company still expects net sales to be up low single digits, now including a flat to low-single-digit negative impact from foreign exchange.”
“The program includes initiatives to optimize the Company’s global supply chain to drive agility and efficiencies.”
“The three-year productivity program includes optimizing the global supply chain to drive agility and efficiencies.”
“The Strategic Growth and Productivity Program will help ensure organizational structure and support to achieve goals.”
“Announced a new three-year productivity program to optimize the global supply chain and reduce overhead costs.”
“Leadership in toothpaste continued with global market share at 41.1% year to date; manual toothbrushes at 32.6%.”
“Leadership in toothpaste continued with global market share at 41.3% year to date; manual toothbrushes at 32.4%.”
“Leadership in toothpaste continued with global market share at 41.2% year to date; manual toothbrushes at 32.4%.”
“Leadership in toothpaste continued with global market share at 41.1% year to date; manual toothbrushes at 32.4%.”
“Advertising spending increased 30 basis points to 13.6% of sales as we invest to drive brand health.”
“Advertising increased 15% in 2024, following a 19% increase in 2023 to support innovation.”
“Advertising increased 16% in the quarter behind science-led innovation across price tiers.”
“Advertising investment expected to be roughly flat as a percentage of net sales.”